- Career Center Home
- Search Jobs
- New Product Assessment Manager
Results
Job Details
Explore Location
UCB
Tokyo, Japan
(on-site)
New Product Assessment Manager
The insights provided are generated by AI and may contain inaccuracies. Please independently verify any critical information before relying on it.
New Product Assessment Manager
The insights provided are generated by AI and may contain inaccuracies. Please independently verify any critical information before relying on it.
Description
Make your mark for patients患者さんのためにあなたの力を発揮してください
Report to: Head of Business Planning Lead
The number of subordinates: None, individual contributor
[Job Purpose]
As a key member of the Japan organization, the New Product Planning Manager will maximize the value of UCB's portfolio in alignment with corporate strategy by leading commercial evaluation and strategic planning for pipeline, product life cycle management and licensing opportunities.
This role bridges science and business, ensuring that development, regulatory, and commercial considerations are integrated to deliver optimal outcomes for both Japanese patients and UCB.
1) Conducting robust commercial assessments of early/late-stage pipeline assets, product lifecycle management and licensing opportunities, including emerging modalities such as gene therapy.
2) Collaborating cross-functionally (Development, Medical, Commercial, Pricing, Regulatory Affairs, and Global teams) to establish Japan-specific commercial, development and submission strategies.
3) Providing strategic recommendations to Japan leadership and Global stakeholders to maximize asset value.
4) Influencing project teams by translating scientific insights into commercial impact and strengthening cross-functional capabilities.
[Major Accountabilities]
Strategic Portfolio Evaluation & Planning
Serve as the hub for all activities related to new product evaluation and planning.
Assess commercial value of pipeline and external opportunities, including:
Epidemiology and disease burden
Medical landscape and unmet needs
Market environment and competitive dynamics
Development strategy and timelines
Pricing, reimbursement, and regulatory considerations
Intellectual property and safety landscape
Ensure alignment of portfolio decisions with UCB's global strategy
Cross-functional Leadership & Alignment
Collaborate with internal stakeholders across functions to align asset strategy.
Facilitate decision-making processes by integrating diverse perspectives into a unified recommendation.
KOL Engagement & Insight Generation
Lead Key Opinion Leader (KOL) mapping and engagement strategy.
Generate actionable insights to support strategic positioning and maximize market potential.
Product Strategy & Business Case Development
Review and maintain Target Product Profiles (TPP) drafted by development team.
Build 5-10-year sales forecasts with robust assumptions.
Consolidate analyses into comprehensive business cases to support investment decisions.
Global Collaboration & Japan Advocacy
Represent Japan's unique clinical, regulatory, and market environment to Global teams.
Identify and communicate opportunities driven by ethnic, scientific, or market-specific differences.
[Quality & Compliance Accountabilities]
Ensure timely and effective communication and escalation across stakeholders, including global alignment and approvals.
Promote a culture of continuous improvement and quality excellence.
Ensure all activities comply with company standards, local regulations, and compliance requirements.
Guarantee accurate and timely reporting of:
Adverse events
Technical complaints
Compliance issues
Complete all mandatory training requirements on time (100% compliance).
[Minimum requirements]
• Experience & Skills
Minimum 5 years of experience in the pharmaceutical industry in areas such as:
New product evaluation and planning
Project management
Business development/licensing
Brand or strategic marketing
Strong combination of scientific and commercial expertise.
Proven ability to work cross-functionally and influence stakeholders without authority.
Experience in strategic analysis, forecasting, and business case development preferred.
Exposure to innovative modalities (e.g., gene therapy) is a plus.
[Education]
Bachelor's degree required in a relevant discipline (e.g., Life Sciences, Medicine, Clinical Research, Marketing, Business Administration).
MBA or advanced degree is an advantage.
[Language]
Fluent English (verbal and written) to effectively engage and influence global stakeholders.
Japanese: Native or business fluency required.
[Mindset & Competencies]
Strong growth mindset with proactive learning orientation.
Strategic thinking and analytical capability.
Effective communication and presentation skills.
Ability to operate in a matrix, global environment.
[Key Success Factors]
Ability to translate complex scientific data into clear commercial insights.
Strong stakeholder management and influence skills.
High level of ownership and accountability.
Strategic agility in a fast-evolving external environment.
患者さんのために価値を創造し、ご自身の力を発揮する準備ができているとお感じでしたら、ぜひ私たちにご連絡ください。
会社概要
UCBは、神経および免疫領域に注力するグローバルなバイオ医薬品企業です。世界中で約8,500人の社員が、患者さんからインスピレーションを受け、科学の力で前進しています。
UCBで働く魅力
UCBでは、単に業務をこなすのではなく、価値を創造することを大切にしています。私たちは挑戦を恐れず、協力し合い、革新を追求しながら、患者さんのために成果を出すことを目指しています。
誰もが尊重され、受け入れられ、最善を尽くせる平等な機会がある、思いやりと支援に満ちた文化が根付いています。
私たちは常に「その先」を目指し、患者さん、社員、そして地球に対して人間らしさを大切にした価値を提供しています。
UCBで働くことで、自分自身の成長を実感し、自由にキャリアを築き、可能性を最大限に引き出すことができます。
UCBでは機会均等を重視しています。すべての採用決定は、法律で保護されているいかなる属性にも関係なく行われます。
選考プロセスにおいて、ご自身の強みや能力を十分に発揮できるよう配慮が必要な場合は、以下のメールアドレスまでご連絡ください:
EMEA-Reasonable_Accommodation@ucb.com
※なお、この問い合わせ先では選考における特別な配慮に関するご相談以外はお受けできませんので、ご注意ください。
Job ID: 85370604
Jobs You May Like
Median Salary
Net Salary per month
$2,683
Cost of Living Index
58/100
58
Median Apartment Rent in City Center
(1-3 Bedroom)
$1,368
-
$2,416
$1,892
Safety Index
76/100
76
Utilities
Basic
(Electricity, heating, cooling, water, garbage for 915 sq ft apartment)
$110
-
$269
$166
High-Speed Internet
$25
-
$50
$30
Transportation
Gasoline
(1 gallon)
$4.24
Taxi Ride
(1 mile)
$5.07
Data is collected and updated regularly using reputable sources, including corporate websites and governmental reporting institutions.
Loading...